Genetic Information Assistant in Telegenetics for Cancer Risk
This study is looking at different ways to provide genetic counseling for people at high risk for certain cancers, especially in rural areas. It compares two methods for pre-test counseling: a Genetic Information Assistant (GIA) chatbot or a standard telegenetics session with a genetic counselor from UVA. The main goal is to see if the type of counseling you receive affects your decision to get genetic testing. You can join if you are 18 or older, at high risk for a genetic cancer, and willing to follow study procedures. The study aims to enroll 96 participants, but its current recruitment status is unclear.
- Study design
- This is an interventional study where participants are randomly assigned to receive pre-test counseling from either a chatbot (Genetic Information Assistant) or a UVA genetic counselor. There are 96 planned participants.
- What's involved
- You will have a pre-test genetic counseling session, answer questions about your cancer genetic knowledge and well-being, provide a saliva sample for genetic testing, and receive your genetic testing results.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, assessing the feasibility of using the chatbot, is measured at 3 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Genetic Information Assistant in Telegenetics
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kari Ring, MD · PRINCIPAL_INVESTIGATOR · University of Virginia
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- To assess feasibility of using a chatbot (GIA) for pre-test genetic counseling compared to standard of care GC3 months
dichotomous measurement of whether the randomized participant completes genetic testing within three months.